Evidence map›Paper›PMID 26211905›Full record

ArticleCancer science2015

Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.

Yingying Feng, Ling Li, Xiaomei Zhang, Yunjing Zhang, Yingchun Liang, Jinjing Lv, Zhongyi Fan, Jing Guo, Tian Hong, Beibei Ji and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. PBX1: a TALE of two seasons-key roles during development and in cancer.Frontiers in cell and developmental biology · 2024
    Review
  2. Comprehensive summary: the role of PBX1 in development and cancers.Frontiers in cell and developmental biology · 2024
    Review
  3. Research progress of PBX1 in developmental and regenerative medicine.International journal of medical sciences · 2023
    Review
  4. Article
  5. mCancer communications (London, England) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Yingying FengDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Ling LiDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Xiaomei ZhangDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, Beijing, China.
Yunjing ZhangDepartment of Colorectal Surgery, the Second Artillery General Hospital, Beijing, China.
Yingchun LiangDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Jinjing LvDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Zhongyi FanDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Jing GuoDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Tian HongDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Beibei JiDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Quanbo JiDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Guohui MeiDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Lihua DingDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Shu ZhangDepartment of Gastrointestinal Oncology, Shandong Cancer Hospital and Institute, Jinan, China.
Xiaojie XuDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Qinong YeDepartment of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
Beijing VDJBio (China) · CNSecond Artillery General Hospital of Chinese People's Liberation Army · CNChinese PLA General Hospital · CNShandong First Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic pre-B cell leukemia transcription factor interacting protein (HPIP) has been shown to play an important role in the development and progression of some cancers. However, the role of HPIP in gastric cancer (GC) is unclear. Here, we show that HPIP is upregulated in most GC patients and promotes GC cell proliferation, migration, and invasion. In GC patients, HPIP positively associates with tumor size and nodal metastasis, and negatively associates with tumor differentiation. Hematopoietic pre-B cell leukemia transcription factor interacting protein increases GC cell proliferation through activation of G1 /S and G2 /M cell cycle transitions, accompanied by a marked increase of the positive cell cycle regulators, including cyclin D1, cyclin A, and cyclin B1. Hematopoietic pre-B cell leukemia transcription factor interacting protein enhances GC cell migration and invasion, and modulates epithelial-mesenchymal transition, which plays a key role in cancer cell migration and invasion. These data underscore the critical role of HPIP in GC cell proliferation and progression and suggest that HPIP inhibition may be a useful therapeutic strategy for GC treatment.

Indexed as

Cell Line, TumorCell MovementCell ProliferationCyclin A1Cyclin B1Cyclin D1DNA-Binding ProteinsEpithelial-Mesenchymal TransitionFemaleG1 Phase Cell Cycle CheckpointsG2 Phase Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansLymphatic MetastasisMaleMiddle AgedCCNA1 protein, humanCCNB1 protein, humanCCND1 protein, humanCyclin A1Cyclin B1Cyclin D1DNA-Binding ProteinsPBX1 protein, humanPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene ProteinsRNA, Small InterferingCell growthEMTgastric cancerHPIPmigration and invasion

Identifiers

PMID26211905
PMCPMC4638003
OpenAlexW2137686264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.